Site icon OncologyTube

Optimising advanced RCC treatment: the place of Fotivda®?(tivozanib) in 2019 and beyond

Manuela Schmidinger, MD, Camillo Porta, MD, Romano Danesi, MD, PhD, Brian I. Rini, MD discuss Optimising advanced RCC treatment: the place of Fotivda®?(tivozanib) in 2019 and beyond at the Kidney Cancer Association International Symposium 2019 in Dubrovnik, Croatia

Exit mobile version